Wockhardt shares saw a significant jump on Tuesday. The pharmaceutical company reported a strong turnaround in its March quarter performance. Net profit turned positive, and revenue saw a substantial increase. Full-year earnings also showed improvement. Biotech operations were a key growth driver, with expansion in emerging markets. The company also expanded its product pipeline with new filings and approvals.
Source :- Markets-Economic Times Read More
